Archive — US — turtlesai
AI and Global Health: New Directions Between Innovation and Governance
The WHO and WEF are promoting AI adoption in global healthcare to enhance efficiency and equity. Companies like Avant Technologies and Palantir are creating AI solutions for clinical challenges. This push could transform the healthcare market, shaping investments and care models significantly.
Key points
- WHO designated the Digital Ethics Centre at Delft University as a Collaborative Centre for AI Governance in Healthcare to ensure ethical AI adoption.
- WEF emphasizes investment in infrastructure, equity, and scientific evidence for effective AI implementation in healthcare.
- Avant Technologies is expanding the Vision AI platform in Latin America to aid in early diagnosis of chronic diseases.
- BioXcel Therapeutics is conducting Phase 3 trials for BXCL501 to treat agitation related to bipolar disorder and schizophrenia.
- Tevogen Bio's PredicTcell platform aims to develop immunologically active peptides.
- Amesite launched NurseMagic™, an AI tool for non-clinical healthcare support.
- Palantir and R1 RCM are optimizing healthcare financial management through the R37 lab and process automation.
Why it matters
- In 2023, AI in healthcare is expected to align with broader IT trends like automation and data-driven decision making.
- The ongoing focus on digital ethics reflects a growing awareness of the implications of technology on society and healthcare.
- Investment in AI healthcare solutions marks a shift towards more integrated and patient-centric care models.
The WHO and WEF's initiatives signal a pivotal moment in global healthcare, potentially reshaping the industry through AI, enhancing patient outcomes and operational efficiencies while emphasizing ethical governance.